Anne E.G. Lenferink

2.5k citations

43 papers · 2.0k indexed · h-index 18

Oncology top 2%
- HER2/EGFR in Cancer Research 11
Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 10
- TGF-β signaling in diseases 7
- Bioinformatics and Genomic Networks 5
- Cancer-related gene regulation 5
- Gene expression and cancer classification 5
Cancer Research top 10%
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research 15
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 6

Co-authors: Carlos L. Arteaga Maureen D. O'Connor‐McCourt Jean F. Simpson James T. Forbes Mark X. Sliwkowski Paul I. Pisacane Hirokazu Kurokawa F. Michael Yakes
Cited by: Oncology Molecular Biology Cancer Research
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (5 papers)Nature Communications (2 papers)
Partner nations: Canada United States Netherlands

In The Last Decade

Anne E.G. Lenferink

43 papers receiving 1.9k citations

Peers

Countries citing papers authored by Anne E.G. Lenferink

Since Specialization

Citations

This map shows the geographic impact of Anne E.G. Lenferink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E.G. Lenferink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E.G. Lenferink more than expected).

Fields of papers citing papers by Anne E.G. Lenferink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E.G. Lenferink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E.G. Lenferink. The network helps show where Anne E.G. Lenferink may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anne E.G. Lenferink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne E.G. Lenferink Line = papers co-authored together Anne E.G. Lenferink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern Frontiers in Immunology ·Tyler M. Renner,Bassel Akache,Matthew Stuible,Nazanin Rohani,Yuneivy Cepero-Donates,Lise Deschatelets,Renu Dudani,Blair A. Harrison,Jason Baardsnes,Izel Koyuturk,Jennifer J. Hill,Usha D. Hemraz,Sophie Régnier,Anne E.G. Lenferink,Yves Durocher,Michael J. McCluskie	2023	6
2	Affinity-controlled capture and release of engineered monoclonal antibodies by macroporous dextran hydrogels using coiled-coil interactions mAbs ·Seyed Farzad Baniahmad,Romane Oliverio,Ines Obregon-Gomez,Alma Robert,Anne E.G. Lenferink,Elena Pazos,Nick Virgilio,Xavier Banquy,Grégory De Crescenzo,Yves Durocher	2023	5
3	Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern npj Vaccines ·Bassel Akache,Tyler M. Renner,Matthew Stuible,Nazanin Rohani,Yuneivy Cepero-Donates,Lise Deschatelets,Renu Dudani,Blair A. Harrison,Christian Gervais,Jennifer J. Hill,Usha D. Hemraz,Edmond Lam,Sophie Régnier,Anne E.G. Lenferink,Yves Durocher,Michael J. McCluskie	2022	15
4	Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors SHILAP Revista de lepidopterología ·Florian Cambay,Céline Raymond,Denis Brochu,Michel Gilbert,The Minh Tu,Christiane Cantin,Anne E.G. Lenferink,Maxime Grail,Olivier Henry,Grégory De Crescenzo,Yves Durocher	2020	15
5	Engineering and Therapeutic Application of Single-Chain Bivalent TGF-β Family Traps Molecular Cancer Therapeutics ·John C. Zwaagstra,Traian Sulea,Jason Baardsnes,Anne E.G. Lenferink,Cathy Collins,Christiane Cantin,Béatrice Paul‐Roc,Suzanne Grothé,Sazzad M. Hossain,Louis-Philippe Richer,Denis L’Abbé,Roseanne Tom,Brian Cass,Yves Durocher,Maureen D. O'Connor‐McCourt	2012	17
6	Molecular imaging of breast tumors using a near‐infrared fluorescently labeled clusterin binding peptide International Journal of Cancer ·Rana Filfil,Béatrice Paul‐Roc,Christiane Cantin,Muhammad Umer Iqbal,Dmitri Tolkatchev,Anna Vinogradova,Ping Xu,Feng Ni,Maureen D. O'Connor‐McCourt,Anne E.G. Lenferink	2011	10
7	Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies Oncogene ·Anne E.G. Lenferink,Christiane Cantin,André Nantel,E. Wang,Yves Durocher,M. Banville,Béatrice Paul‐Roc,Anne Marcil,Mark R. Wilson,Maureen D. O'Connor‐McCourt	2009	74
8	Escherichia coli expression and refolding of E/K-coil-tagged EGF generates fully bioactive EGF for diverse applications Protein Expression and Purification ·Phuong Uyen Le,Anne E.G. Lenferink,Maxime Pinard,Jason Baardsnes,Bernard Massie,Maureen D. O'Connor‐McCourt	2008	16
9	Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-β and Neu pathway signaling studies: identification of a novel model for TGF-β-induced epithelial-to-mesenchymal transition Breast Cancer Research ·Anne E.G. Lenferink,Joanne Magoon,Christiane Cantin,Maureen D. O'Connor‐McCourt	2004	15
10	Expression of TGF‐β type II receptor antisense RNA impairs TGF‐β signaling in vitro and promotes mammary gland differentiation in vivo International Journal of Cancer ·Anne E.G. Lenferink,Joanne Magoon,Marie‐Claude Pepin,Alain Guimond,Maureen D. O'Connor‐McCourt	2003	15
11	ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. PubMed ·Anne E.G. Lenferink,Dagmar Busse,W. Michael Flanagan,F. Michael Yakes,Carlos L. Arteaga	2001	156
12	Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function The Journal of Cell Biology ·Rebecca S. Muraoka,Anne E.G. Lenferink,Jean F. Simpson,Dana M. Brantley,L. Renee Roebuck,F. Michael Yakes,Carlos L. Arteaga	2001	67
13	Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. PubMed ·Hirokazu Kurokawa,Anne E.G. Lenferink,Jean F. Simpson,Paul I. Pisacane,Mark X. Sliwkowski,James T. Forbes,Carlos L. Arteaga	2000	310
14	Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice Proceedings of the National Academy of Sciences ·Anne E.G. Lenferink,Jean F. Simpson,Laura K. Shawver,Robert J. Coffey,James T. Forbes,Carlos L. Arteaga	2000	112
15	The EGF domain: Requirements for binding to receptors of the ErbB family Vitamins and hormones ·E.J.J. van Zoelen,Catelijne Stortelers,Anne E.G. Lenferink,Monique L. M. Van de Poll	2000	37
16	The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin Oncogene ·Ronit Pinkas‐Kramarski,Anne E.G. Lenferink,Sarah Bacus,Ljuba Lyass,Monique LM van de Poll,Leah N. Klapper,Eldad Tzahar,Michael Sela,Everardus JJ van Zoelen,Yosef Yarden	1998	75
17	Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers The EMBO Journal ·Anne E.G. Lenferink	1998	322
18	Identification of the Minimal Requirements for Binding to the Human Epidermal Growth Factor (EGF) Receptor Using Chimeras of Human EGF and an EGF Repeat of Drosophila Notch Journal of Biological Chemistry ·Monique L.M. van de Poll,Marianne J.H. van Vugt,Anne E.G. Lenferink,E.J.J. van Zoelen	1998	15
19	Rational Design for the Development of Epidermal Growth Factor Receptor Antagonists Pathology - Research and Practice ·E.J.J. van Zoelen,Anne E.G. Lenferink,R.H. Kramer,Monique L. M. Van de Poll	1996	8
20	A Single Amino Acid Exchange, Arg-45 to Ala, Generates an Epidermal Growth Factor (EGF) Mutant with High Affinity for the Chicken EGF Receptor Journal of Biological Chemistry ·Monique L.M. van de Poll,Anne E.G. Lenferink,Marianne J.H. van Vugt,Jacqueline J.L. Jacobs,Jannie W.H. Janssen,Manon Joldersma,E.J.J. van Zoelen	1995	23

About Anne E.G. Lenferink

Anne E.G. Lenferink is a scholar working on Immunology and Allergy, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (11 papers), Glycosylation and Glycoproteins Research (10 papers), TGF-β signaling in diseases (7 papers), Cell Adhesion Molecules Research (6 papers), Bioinformatics and Genomic Networks (5 papers), Cancer-related gene regulation (5 papers) and Gene expression and cancer classification (5 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (1.3k citations) and Cancer Research (280 citations). Anne E.G. Lenferink has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Carlos L. Arteaga, Maureen D. O'Connor‐McCourt, Jean F. Simpson, James T. Forbes, Mark X. Sliwkowski, Paul I. Pisacane, Hirokazu Kurokawa, F. Michael Yakes, E. Wang and Edwin Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact